Literature DB >> 29438582

Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics.

Stefan Koppermann1, Zheng Cui2, Patrick D Fischer1, Xiachang Wang3,4, Jannine Ludwig1, Jon S Thorson2,4, Steven G Van Lanen2, Christian Ducho1.   

Abstract

Muraymycins are a subclass of antimicrobially active uridine-derived natural products. Biological data on several muraymycin analogues have been reported, including some inhibitory in vitro activities toward their target protein, the bacterial membrane enzyme MraY. However, a structure-activity relationship (SAR) study on naturally occurring muraymycins based on such in vitro data has been missing so far. In this work, we report a detailed SAR investigation on representatives of the four muraymycin subgroups A-D using a fluorescence-based in vitro MraY assay. For some muraymycins, inhibition of MraY with IC50 values in the low-picomolar range was observed. These inhibitory potencies were compared with antibacterial activities and were correlated to modelling data derived from a previously reported X-ray crystal structure of MraY in complex with a muraymycin inhibitor. Overall, these results will pave the way for the development of muraymycin analogues with optimized properties as antibacterial drug candidates.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  activity assays; antibiotics; natural products; nucleosides; structure-activity relationships

Mesh:

Substances:

Year:  2018        PMID: 29438582      PMCID: PMC6019934          DOI: 10.1002/cmdc.201700793

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  37 in total

1.  EVIDENCE FOR AN INITIAL ACCEPTOR OF UDP-NAC-MURAMYL-PENTAPEPTIDE IN THE SYNTHESIS OF BACTERIAL MUCOPEPTIDE.

Authors:  W G STRUVE; F C NEUHAUS
Journal:  Biochem Biophys Res Commun       Date:  1965-01-04       Impact factor: 3.575

2.  Crystal structure of MraY, an essential membrane enzyme for bacterial cell wall synthesis.

Authors:  Jinshi Zhao; Robert A Gillespie; Ben C Chung; Do-Yeon Kwon; Ziqiang Guan; Jiyong Hong; Pei Zhou; Seok-Yong Lee
Journal:  Science       Date:  2013-08-30       Impact factor: 47.728

3.  The bacteria fight back.

Authors:  Gary Taubes
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

4.  Slow binding inhibition of phospho-N-acetylmuramyl-pentapeptide-translocase (Escherichia coli) by mureidomycin A.

Authors:  P E Brandish; M K Burnham; J T Lonsdale; R Southgate; M Inukai; T D Bugg
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

5.  MraY-antibiotic complex reveals details of tunicamycin mode of action.

Authors:  Jonna K Hakulinen; Jenny Hering; Gisela Brändén; Hongming Chen; Arjan Snijder; Margareta Ek; Patrik Johansson
Journal:  Nat Chem Biol       Date:  2017-01-09       Impact factor: 15.040

6.  Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.

Authors:  Tetsuya Tanino; Bayan Al-Dabbagh; Dominique Mengin-Lecreulx; Ahmed Bouhss; Hiroshi Oyama; Satoshi Ichikawa; Akira Matsuda
Journal:  J Med Chem       Date:  2011-11-15       Impact factor: 7.446

7.  Topological analysis of the MraY protein catalysing the first membrane step of peptidoglycan synthesis.

Authors:  A Bouhss; D Mengin-Lecreulx; D Le Beller; J Van Heijenoort
Journal:  Mol Microbiol       Date:  1999-11       Impact factor: 3.501

Review 8.  Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides.

Authors:  Timothy D H Bugg; Maria T Rodolis; Agnes Mihalyi; Shirin Jamshidi
Journal:  Bioorg Med Chem       Date:  2016-03-09       Impact factor: 3.641

9.  Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.

Authors:  Ben C Chung; Ellene H Mashalidis; Tetsuya Tanino; Mijung Kim; Akira Matsuda; Jiyong Hong; Satoshi Ichikawa; Seok-Yong Lee
Journal:  Nature       Date:  2016-04-18       Impact factor: 49.962

Review 10.  Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents.

Authors:  Daniel Wiegmann; Stefan Koppermann; Marius Wirth; Giuliana Niro; Kristin Leyerer; Christian Ducho
Journal:  Beilstein J Org Chem       Date:  2016-04-22       Impact factor: 2.883

View more
  9 in total

1.  Self-Resistance during Muraymycin Biosynthesis: a Complementary Nucleotidyltransferase and Phosphotransferase with Identical Modification Sites and Distinct Temporal Order.

Authors:  Zheng Cui; Xia-Chang Wang; Xiaodong Liu; Anke Lemke; Stefan Koppermann; Christian Ducho; Jürgen Rohr; Jon S Thorson; Steven G Van Lanen
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

2.  Antibacterial Muraymycins from Mutant Strains of Streptomyces sp. NRRL 30471.

Authors:  Zheng Cui; Xiachang Wang; Stefan Koppermann; Jon S Thorson; Christian Ducho; Steven G Van Lanen
Journal:  J Nat Prod       Date:  2018-03-19       Impact factor: 4.050

3.  Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.

Authors:  Seung-Hwa Kwak; Won Young Lim; Aili Hao; Ellene H Mashalidis; Do-Yeon Kwon; Pyeonghwa Jeong; Mi Jung Kim; Seok-Yong Lee; Jiyong Hong
Journal:  Eur J Med Chem       Date:  2021-02-06       Impact factor: 6.514

4.  Analogues of Muraymycin Nucleoside Antibiotics with Epimeric Uridine-Derived Core Structures.

Authors:  Anatol P Spork; Stefan Koppermann; Stephanie Schier Née Wohnig; Ruth Linder; Christian Ducho
Journal:  Molecules       Date:  2018-11-03       Impact factor: 4.411

5.  Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity.

Authors:  Bei Zhang; Timothy J Kopper; Xiaodong Liu; Zheng Cui; Steven G Van Lanen; John C Gensel
Journal:  CNS Neurosci Ther       Date:  2019-01-24       Impact factor: 5.243

6.  Chemical logic of MraY inhibition by antibacterial nucleoside natural products.

Authors:  Ellene H Mashalidis; Benjamin Kaeser; Yuma Terasawa; Akira Katsuyama; Do-Yeon Kwon; Kiyoun Lee; Jiyong Hong; Satoshi Ichikawa; Seok-Yong Lee
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

7.  Towards Zwitterionic Oligonucleotides with Improved Properties: the NAA/LNA-Gapmer Approach.

Authors:  Melissa Wojtyniak; Boris Schmidtgall; Philine Kirsch; Christian Ducho
Journal:  Chembiochem       Date:  2020-08-28       Impact factor: 3.164

8.  Muraymycin Nucleoside Antibiotics: Structure-Activity Relationship for Variations in the Nucleoside Unit.

Authors:  Anna Heib; Giuliana Niro; Stefanie C Weck; Stefan Koppermann; Christian Ducho
Journal:  Molecules       Date:  2019-12-19       Impact factor: 4.411

9.  A Sub-Micromolar MraYAA Inhibitor with an Aminoribosyl Uridine Structure and a (S,S)-Tartaric Diamide: Synthesis, Biological Evaluation and Molecular Modeling.

Authors:  Martin Oliver; Laurent Le Corre; Mélanie Poinsot; Michaël Bosco; Hongwei Wan; Ana Amoroso; Bernard Joris; Ahmed Bouhss; Sandrine Calvet-Vitale; Christine Gravier-Pelletier
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.